Cargando…
Comparison of Positive Inotropic Agents in the Management of Acute Decompensated Heart Failure
Current guidelines recommend the consideration of positive inotropes in patients with acute decompensated heart failure (ADHF) who have low cardiac index and evidence of systemic hypoperfusion or congestion. However, there is no evidence detailing the first line agent for the management of ADHF. The...
Autores principales: | Kelly, Julie, Cheng, Judy, Malloy, Rhynn, Lupi, Kenneth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Journal of Cardiovascular Pharmacology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7249484/ https://www.ncbi.nlm.nih.gov/pubmed/32091426 http://dx.doi.org/10.1097/FJC.0000000000000811 |
Ejemplares similares
-
Agents with inotropic properties for the management of acute heart failure syndromes. Traditional agents and beyond
por: Teerlink, John R., et al.
Publicado: (2009) -
Prognosis and risk stratification in patients with decompensated heart failure receiving inotropic therapy
por: Gomes, Clara, et al.
Publicado: (2018) -
Efficacy of the New Inotropic Agent Istaroxime in Acute Heart Failure
por: Forzano, Imma, et al.
Publicado: (2022) -
Use of Inotropic Agents in Treatment of Systolic Heart Failure
por: Tariq, Sohaib, et al.
Publicado: (2015) -
Comparison of anticoagulated versus non-anticoagulated patients with intra-aortic balloon pumps
por: Kelly, Julie, et al.
Publicado: (2021)